Session Summary

The use of i2b2 for determining feasibility of clinical studies and clinical trials, focusing on the use of i2b2 in networks across the country, and novel approaches to allowing investigators to perform feasibility studies using i2b2-based client tools.

 

Presenter (4)
Presentations

Douglas MacFadden

<html>
<body>
<p class="i2b2-event-presenter-position">Chief Informatics Officer</p>
<p class="i2b2-event-presenter-company">Harvard Catalyst</p>
</body>
</html>

P1: SHRINE Update
  • Review of all the new features added to the SHRINE Software

 

 

 

Nich Wattanasin, MS

<html>
<body>
<p class="i2b2-event-presenter-position">Corporate Team Lead</p>
<p class="i2b2-event-presenter-company">Partners HealthCare</p>
</body>
</html>
 

 

P2: Feasibility Studies Using SHRINE and i2b2
  • New features added to SHRINE and i2b2 Web Clients to help improve the workflow of identifying and extracting patient sets for clinical studies or trials.

 

 

 

 

 

Jack London, MD

 

P3: 

 

 

 

Kavi Wagholikar, PhD

 

<html>
<body>
<p class="i2b2-event-presenter-position">Assistant in Computer Science</p>
<p class="i2b2-event-presenter-company">Massachusetts General Hospital</p>
</body>
</html>

P4: SMART on FHIR on i2b2
  • Review of new FHIR cell
  • Standardizing docker containers